{"entity":{"type":"insider","cik":"0001442674","url":"/insider/0001442674","json_url":"/insider/0001442674.json","name":"Anderson Stephen Charles","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":4,"first":"2008-08-27","last":"2008-11-17","span_basis":"filed_date"},"name_variants":[{"name":"Anderson Stephen Charles","source":"filing","n_filings":4,"first_seen":"2008-08-27","last_seen":"2008-11-17"}],"transactions":[{"id":9266026,"accession":"0001209191-08-060639","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-060639","line_url":"/filing/0001209191-08-060639#line-2","is_derivative":false,"issuer_cik":"0001442674","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0001442674","owner_cik":"0001442674","owner_name":"Anderson Stephen Charles","owner_display_name":"Anderson Stephen Charles","owner_url":"/insider/0001442674","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2224.0,"shares_display":"2,224","price_per_share":2.4,"price_display":"2.40","price_state":"stated","total_value":5337.6,"total_display":"5,337.60","total_whole":"5,338","shares_owned_after":13000.0,"shares_owned_after_display":"13,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-14","scope":"insider"},{"id":3208337,"accession":"0001209191-08-060566","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-060566","line_url":"/filing/0001209191-08-060566#line-2","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001442674","owner_name":"Anderson Stephen Charles","owner_display_name":"Anderson Stephen Charles","owner_url":"/insider/0001442674","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2224.0,"shares_display":"2,224","price_per_share":2.4,"price_display":"2.40","price_state":"stated","total_value":5337.6,"total_display":"5,337.60","total_whole":"5,338","shares_owned_after":2224.0,"shares_owned_after_display":"2,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-13","scope":"insider"},{"id":9266027,"accession":"0001209191-08-060639","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-060639","line_url":"/filing/0001209191-08-060639#line-1","is_derivative":false,"issuer_cik":"0001442674","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0001442674","owner_cik":"0001442674","owner_name":"Anderson Stephen Charles","owner_display_name":"Anderson Stephen Charles","owner_url":"/insider/0001442674","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":776.0,"shares_display":"776","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":1940.0,"total_display":"1,940.00","total_whole":"1,940","shares_owned_after":10776.0,"shares_owned_after_display":"10,776","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-12","filed_date":"2008-11-14","scope":"insider"},{"id":3208329,"accession":"0001209191-08-060566","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-060566","line_url":"/filing/0001209191-08-060566#line-1","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001442674","owner_name":"Anderson Stephen Charles","owner_display_name":"Anderson Stephen Charles","owner_url":"/insider/0001442674","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":776.0,"shares_display":"776","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":1940.0,"total_display":"1,940.00","total_whole":"1,940","shares_owned_after":776.0,"shares_owned_after_display":"776","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-12","filed_date":"2008-11-13","scope":"insider"},{"id":9266032,"accession":"0001209191-08-060918","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-060918","line_url":"/filing/0001209191-08-060918","is_derivative":false,"issuer_cik":"0001442674","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0001442674","owner_cik":"0001442674","owner_name":"Anderson Stephen Charles","owner_display_name":"Anderson Stephen Charles","owner_url":"/insider/0001442674","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":6.77,"price_display":"6.77","price_state":"stated","total_value":67700.0,"total_display":"67,700.00","total_whole":"67,700","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-08-26","filed_date":"2008-11-17","scope":"insider","n_lines":3},{"id":2944395,"accession":"0001209191-08-049392","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-08-049392","line_url":"/filing/0001209191-08-049392","is_derivative":false,"issuer_cik":"0000949858","issuer_name":"ONCOGENEX PHARMACEUTICALS, INC.","issuer_ticker":"OGXI","issuer_name_source":null,"issuer_url":"/issuer/0000949858","owner_cik":"0001442674","owner_name":"Anderson Stephen Charles","owner_display_name":"Anderson Stephen Charles","owner_url":"/insider/0001442674","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":6.77,"price_display":"6.77","price_state":"stated","total_value":67700.0,"total_display":"67,700.00","total_whole":"67,700","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-08-26","filed_date":"2008-08-27","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000949858","name":"ONCOGENEX PHARMACEUTICALS, INC.","url":"/issuer/0000949858","role":"Officer (CFO and Secretary)","n_filings":4,"first_seen":"2008-08-27","last_seen":"2008-11-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001442674","retrieved_at":"2026-08-27T03:15:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}